Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis
{{output}}
Subjects affected by thalassemia major (TM) often have reduced bone mass and increased fracture risk. Strontium ranelate (SrR) is an effective treatment for postmenopausal and male osteoporosis. To date, no data exist on the use of SrR in the treatment of TM-r... ...
